Before the pandemic, BioNTech was a small biotech company primarily focused on developing novel cancer treatments. Here's how BioNTech emerged as a powerhouse in the Covid vaccine race. Watch the full video here: https://t.co/7rlmGDS3MT pic.twitter.com/zj4u5tu1kA
— CNBC (@CNBC) January 22, 2022